Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Cash flows from operating activities
Net loss	$ (3,108,991)	$ (4,112,420)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	256,358	188,819
Change in fair value of warrant liability	(3,967)	(51,081)
Changes in operating assets and liabilities:
Advances on research and development contract services	49,087	70,785
Prepaid insurance	35,233	104,171
Interest receivable	(9,895)
Accounts payable and accrued expenses	91,025	89,780
Accrued legal settlement		(414,989)
Net cash used in operating activities	(2,691,150)	(4,124,935)
Cash flows from financing activities
Proceeds from issuance of common shares from ATM, net of costs	347,549	1,112,202
Proceeds from sale of common stock, warrants, and pre-funded warrants in public offering, net of offering costs	4,352,792	1,504,113
Proceeds from issuance of common shares from warrant inducement, net of costs		1,806,520
Exercise of pre-funded warrants		662
Net cash provided by financing activities	4,700,341	4,423,497
Net increase in cash	2,009,191	298,562
Cash, beginning of year	3,325,131	3,026,569
Cash, end of year	5,334,322	3,325,131
Supplemental information
Income taxes paid
Noncash investing and financing activities
Options issued to settle accrued bonus	46,183	77,400
Deemed dividend – warrant inducement		$ 3,212,504